18
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer

, , , , &
Pages 240-246 | Received 03 Sep 2007, Published online: 03 Aug 2009
 

Abstract

Background. The aim of this study was to determine predictors for loco-regional or distant recurrence of disease in a subgroup of intermediate or high risk stage I and II endometrial cancer. Methods. A retrospective analysis of 295 patients with histopathological stage I and II, intermediate or high risk endometrial cancer is reported. The following factors were studied: stage, grade, age, histologic diagnosis, lymphadenectomy, lymphovascular space invasion, and adjuvant radiotherapy. The Log-Rank test was used for statistical analyses and the Kaplan–Meyer method was used for time-to-event analysis. Multivariate analysis was also performed. Results. Thirty-four (11.5%) patients developed a recurrence; 20 (59%) developed loco-regional recurrence, and 14 (41%) developed distant recurrence. In 20 women (59%), recurrence appeared within 3 years of surgery, and the actuarial survival at 3 years after recurrence was 29%. Multivariate analysis showed that for recurrence, age >60 years was a significant unfavourable prognostic factor (p < 0.05). Conclusions. We found low rates of recurrence in patients with early stage intermediate or high risk endometrial cancer. Only age was identified as an independent significant predictor for recurrence.

Abbreviations
ASTEC=

A study in the treatment of endometrial cancer

FIGO=

International Federation of Gynaecology and Obstetrics

LVSI=

lymphovascular space invasion

TAH-BSO=

total abdominal hysterectomy and bilateral salpingo-oophorecomy

PORTEC=

Post-Operative Radiation Therapy in Endometrial Cancer

Abbreviations
ASTEC=

A study in the treatment of endometrial cancer

FIGO=

International Federation of Gynaecology and Obstetrics

LVSI=

lymphovascular space invasion

TAH-BSO=

total abdominal hysterectomy and bilateral salpingo-oophorecomy

PORTEC=

Post-Operative Radiation Therapy in Endometrial Cancer

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.